Concepedia

Author

Noori Maka

Queen Elizabeth University Hospital

Also Known As

Jennifer Hay, Maka, Noori, Maurice B. Loughrey, N. Maka, Noori Maka

50

Publications

684

Citations

11

H-Index

17

Concepts

All Affiliations

Queen Elizabeth University HospitalUniversity of GlasgowThe Christie NHS Foundation TrustInstitute of Cancer ResearchCancer Research UK Scotland Institute
NM

About

Noori Maka is an author at Queen Elizabeth University Hospital specializing in physiology, medicine, and developmental biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

224

2

Developmental Biology

2

2

224

3

Public Health

1

1

56

4

Endocrinology

1

1

56

5

Nutrition

1

1

56

Noori Maka

×

8

Publications

372

Citations

8

H-Index

YearCitations

Effect of Intrauterine Growth Restriction on the Number of Cardiomyocytes in Rat Hearts

Hugo Brandt Corstius, Monika Zimanyi, Noori Maka,

Pediatric Research

2005

168

Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring

Noori Maka, John Makrakis, Helena C. Parkington,

Pediatric Nephrology

2007

56

JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors

Kathryn A.F. Pennel, Phimmada Hatthakarnkul, Colin S. Wood,

Journal of Experimental & Clinical Cancer Research

2024

38

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

Hazel Lote, Inmaculada Spiteri, Luca Ermini,

Annals of Oncology

2017

28

Prognostic and Predictive Value of Immunoscore in Stage III Colorectal Cancer: Pooled Analysis of Cases From the SCOT and IDEA-HORG Studies

Enric Domingo, Caroline Kelly, Jennifer Hay,

Journal of Clinical Oncology

2024

23

Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis

Anja Frei, Anthony McGuigan, Ritik RAK Sinha,

The Lancet Oncology

2024

21

Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer

M. Polack, Marloes Smit, Gabi W. van Pelt,

ESMO Open

2024

21

Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)

Catherine Hanna, Séan M. O’Cathail, Janet Graham,

Radiation Oncology

2021

17

Page 1